Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
10/27/2011 | US20110262438 Biological materials related to cxcr7 |
10/27/2011 | US20110262432 mutated netrin 4 proteins, fragments thereof and their uses as drugs |
10/27/2011 | US20110262407 Treatment with alpha7 selective ligands |
10/27/2011 | US20110262396 Combination treatments comprising protease binding proteins for inflammatory disorders |
10/27/2011 | US20110262392 Medium derived from stem cells as a pharmaceutical composition |
10/27/2011 | US20110262388 Novel inhibitors |
10/27/2011 | US20110262386 Methods of treating inflammation |
10/27/2011 | US20110262374 Novel compound ramalin and use thereof |
10/27/2011 | US20110262373 Personalised pharmaceutical composition containing retinoic acid, for anti-aging of the skin |
10/27/2011 | US20110262368 C21 thioethers as glucocorticoid receptor agonists |
10/27/2011 | CA2796592A1 Compounds provided with antioxidant activity against free radicals, and pharmaceutical and cosmetic compositions containing them |
10/26/2011 | EP2380912A1 Novel anti-IGF-IR antibodies and uses thereof |
10/26/2011 | EP2380890A1 New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors |
10/26/2011 | EP2380877A1 Pyridine-3-carboxyamide derivative |
10/26/2011 | EP2380872A1 Polycationic compounds and uses thereof |
10/26/2011 | EP2380850A1 Modified sodium-montmorillonite, preparing method and uses thereof |
10/26/2011 | EP2380578A1 Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent |
10/26/2011 | EP2379548A1 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases |
10/26/2011 | EP2379533A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity |
10/26/2011 | EP2379484A1 Polyunsaturated fatty acid and diol ester as an anti-acne agent |
10/26/2011 | EP2379082A2 Acne treatment powder foundation |
10/26/2011 | EP2379063A1 Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix |
10/26/2011 | EP2379062A1 Pharmaceutical composition comprising one or more fumaric acid esters |
10/26/2011 | EP2378876A1 Lower dosage strength imiquimod formulations and short dosing regimens for treating actinic keratosis |
10/26/2011 | EP2378873A1 Method of treating neuropathic pain |
10/26/2011 | EP2378872A1 Acne vulgaris treatment regimen |
10/26/2011 | EP2117499B1 Use of sinapic acid in non-therapeutic cosmetic and/or topical compositions |
10/26/2011 | EP1631293B1 Compounds, formulations, and methods for treating or preventing rosacea |
10/26/2011 | EP1587477B1 Odorless formulation for treating mucosal discontinuities |
10/26/2011 | EP1469310B1 Diagnostic for scleroderma |
10/26/2011 | CN102227427A Cyclobutyl purine derivative, angiogenesis promoting agent, lumenization promoting agent, neurocyte growth promoting agent, and drug |
10/26/2011 | CN102227409A Pyridine-3-carboxyamide derivative |
10/26/2011 | CN102227223A Mineral absorption improver, and method for improving absorption of minerals |
10/26/2011 | CN102227221A Pharmaceutical combination containing hsp90 inhibitor and mtor inhibitor |
10/26/2011 | CN102227220A Hsp90 inhibitors for therapeutic treatment |
10/26/2011 | CN102227208A Drug or dermatological composition containing avocado peptide extract for treating and preventing pruritus |
10/26/2011 | CN102225896A Ether derivatives of rhein and their therapeutic use |
10/26/2011 | CN102225205A Tripterine nano structure lipid carrier and preparation method and application thereof |
10/26/2011 | CN102225201A New application of glycolytic inhibitor |
10/26/2011 | CN102225194A Use of Bv8 and/or EG-VEGF to promote hematopoiesis |
10/26/2011 | CN102225189A Preparation method of baste for eliminating bruise |
10/26/2011 | CN102225178A Fructus galangae extract and medicinal application thereof |
10/26/2011 | CN102225170A Honeysuckle and broom cypress fruit carminative liquid |
10/26/2011 | CN102225156A Plaster for external use for treating dermatophytosis |
10/26/2011 | CN102225143A Medicine for external use for treating psoriasis |
10/26/2011 | CN102225142A Itch relieving ointment for women |
10/26/2011 | CN102225134A Medicament for treating alopecia and preparation method thereof |
10/26/2011 | CN102225124A Plaster for treating leg ecthyma and skin fester |
10/26/2011 | CN102225121A Preparation method of medicament for treating scalding |
10/26/2011 | CN102225118A Blood-activating wind-dispelling liquid |
10/26/2011 | CN102225114A Medicine for treating foot ringworm and preparation method thereof |
10/26/2011 | CN102225113A Traditional Chinese medicine preparation for treating animal dermatosis |
10/26/2011 | CN102225075A Method for preparing beriberi emulsion |
10/26/2011 | CN102225072A Sodium humate skin external preparation for promoting wound healing |
10/26/2011 | CN102225071A Preparation method of external medicine for treating tinea manuum and tinea pedis |
10/26/2011 | CN102225064A Application of isoflavone compound in preparing medicines for treating radiation injuries |
10/26/2011 | CN102225038A Preparation method of hair growth liquid |
10/26/2011 | CN102224975A Soaking liquid medicine for treating tinea manus and pedis and medical healthcare product |
10/26/2011 | CN101912483B Traditional Chinese medicine embrocation of children infantile eczema |
10/26/2011 | CN101874777B Spray containing butenafine hydrochloride |
10/26/2011 | CN101837082B Chinese preparation for treating burn without leaving scar |
10/26/2011 | CN101837016B Chinese medicinal preparation for curing trauma |
10/26/2011 | CN101791344B Traditional Chinese medicine and preparation method thereof |
10/26/2011 | CN101518614B Chinese patent medicine for treating chloasma |
10/26/2011 | CN101513502B Hair growth medicament |
10/26/2011 | CN101337028B Impregnation medicine for treating footpad bromidrosis |
10/26/2011 | CN101337027B Oral traditional Chinese medicine for treating kidney-water depletion type chloasma |
10/26/2011 | CN101306148B Traditional Chinese medicine orally taken for treating intractable psoriasis |
10/26/2011 | CN101306141B Decoction for treating qi-blood disharmony type vitiligo |
10/26/2011 | CN101301442B Decoction for treating papulopustular type acne |
10/26/2011 | CN101301344B Oral Chinese medicine for treating blood-heat drug induced dermatitis |
10/26/2011 | CN101199706B Medicinal oil medicament for treating burn |
10/26/2011 | CN101194975B Powder medicament for treating impetigo |
10/26/2011 | CN101185686B Powder agent medicine for treating eczema |
10/26/2011 | CN101181499B Pharmaceutical combination for curing acne as well as preparations and preparation thereof |
10/26/2011 | CN101048166B Abnormal protein removing composition |
10/25/2011 | US8044207 Pyridinoylpiperidines as 5-HT1F agonists |
10/25/2011 | US8044182 Adiponectin and uses thereof |
10/25/2011 | US8044042 Thienotriazolodiazepine compound and medicinal use thereof |
10/25/2011 | US8044040 e.g. 3-{3-Cyano-6-[(2,2-dimethyl-propyl)-methyl-amino]-5-fluoro-pyridin-2-ylamino}-N-methoxy-4-methyl-benzamide; via p38 kinase inhibition; (anilino)(halo)pyrimidine or (anilino)(amino)pyrimidine derivatives; rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis |
10/25/2011 | US8043855 vector contains an adenoviral genome from which the open reading frames E1 and/or E3 have been deleted, but retains enough sequence to make it able to replicate in vitro; also contains a DNA sequence regulated by promoters that encode for fibrosis treatment proteins |
10/25/2011 | US8043624 Compositions and methods for treatment of microbial infections |
10/25/2011 | CA2505538C Papaya puree and its use |
10/25/2011 | CA2484020C Re-epithelializing pharmaceutical compositions comprising xanthan gum |
10/25/2011 | CA2460834C Matrix metalloproteinase inhibitor |
10/20/2011 | WO2011130342A1 FUSED DERIVATIVES AS ΡI3Κδ INHIBITORS |
10/20/2011 | WO2011130246A2 Compositions with reactive ingredients, and wound dressings, apparatuses, and methods |
10/20/2011 | WO2011129781A1 Diabetic foot processor system |
10/20/2011 | WO2011129588A2 Polymer/liposome nanocomposite composition for percutaneous absorption, and method for preparing same |
10/20/2011 | WO2011129428A1 Cosmetic composition containing plum extract |
10/20/2011 | WO2011129424A1 Pharmaceutical agent for prevention and/or treatment of htlv-1-associated myelopathy |
10/20/2011 | WO2011129399A1 Srebp inhibitor |
10/20/2011 | WO2011128745A2 Fully openable multifunction drawer for household appliances |
10/20/2011 | WO2011127994A1 Active substance complex and formulation comprising it |
10/20/2011 | WO2011127532A1 Tethered matrix metalloproteinase inhibitor |
10/20/2011 | WO2011047173A9 Pharmaceutical compositions for oral administration |
10/20/2011 | US20110258713 Compositions and methods for re-programming cells without genetic modification |
10/20/2011 | US20110257271 Derivatives of dimethylcurcumin |
10/20/2011 | US20110257264 Use of 2,5-dihydroxybenzene derivatives for treating actinic keratosis |
10/20/2011 | US20110257262 Crystalline ingenol mebutate |